Zhang, Kai
Toki, Hidetoh
Fujita, Yuko
Ma, Min
Chang, Lijia
Qu, Youge
Harada, Shingo
Nemoto, Tetsuhiro
Mizuno-Yasuhira, Akiko
Yamaguchi, Jun-ichi
Chaki, Shigeyuki
Hashimoto, Kenji
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18dm0107119)
Article History
Received: 18 July 2018
Accepted: 29 August 2018
First Online: 13 September 2018
Compliance with ethical standards
:
: Dr. Hashimoto is an inventor on a filed patent application on “The use of (<i>R</i>)-ketamine in the treatment of psychiatric diseases” by Chiba University. Dr. Hashimoto has received research support from Dainippon-Sumitomo, Otsuka, and Taisho. Drs. Toki, Mizuno-Yasuhira, Yamaguchi, and Chaki are employee of Taisho Pharmaceutical Co., Ltd., Japan. Other authors declare no conflict of interest.